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INTRODUCTION
Despite continuous improvements in intensive care medicine
and antibiotic therapy, bacterial meningitis remains a serious
disease at any age, and is still accompanied by significantly
high mortality and neurologic morbidity in survivors. The
prognosis is particularly poor in neonates, with mortality
rates of 20-40% and long-term neurologic sequelae in up to
50% of survivors (1). Although the precise mechanism of
neuronal injury has not been completely delineated, host
inflammatory responses to bacterial components in the sub-
arachnoid space including increased intracranial pressure
(ICP), increase in cytokines, leukocytes, and lactate in the
cerebrospinal fluid (CSF) (2, 3), and cerebral ischemia result-
ing from reduced cerebral perfusion pressure (CPP) due to
intracranial hypertension and/or systemic hypotension (2, 4,
5), are presumed to be responsible for much of brain injury
during bacterial meningitis. Therefore, the development of
new adjunctive therapy to antibiotics aimed at attenuating
acute inflammatory responses and reducing cerebral ischemia
would be necessary to improve the prognosis of this disease.
Hypertonic saline (HTS) has been primarily used as an
initial therapy in severe hypovolemic shock associated with
trauma in context with small-volume resuscitation (6), how-
ever, its use is being considered in various conditions includ-
ing perioperative setting (7), burn injury (8), sepsis syndrome
(9), and brain injury (10). In animal studies, HTS immedi-
ately increases mean arterial pressure (MAP) (11), enhances
cardiac function (12), and restores microvascular perfusion
(13). HTS also decreases the rising of ICP and improves CPP
and regional CBF in various animal studies (14, 15). Accord-
ing to recent in vitro studies, HTS also possesses significant
anti-inflammatory capabilities (16-18). HTS can interfere
with neutrophil-endothelial cell interaction (16), inhibits
lipopolysaccharide-induced nitric oxide synthase expression
by inhibiting nuclear factor kappa B (17), and attenuate the
neutrophil cytotoxic response by interfering with intracellu-
lar signal transduction (18). These features make HTS an
attractive therapeutic agent to attenuate neuronal injury by
improving CPP and down-regulating acute inflammatory
responses in bacterial meningitis.
In the present study, we evaluated the efficacy of HTS as
an adjunctive therapy in attenuating brain damage in experi-
mental neonatal bacterial meningitis. We tested the hypothe-
sis that HTS attenuates brain injury by improving CPP and
down-regulating acute inflammatory responses in experimen-
tal Escherichia coli meningitis in the newborn piglet.
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Effects of Hypertonic (7%) Saline on Brain Injury in Experimental
Escherichia coli Meningitis
We sought to know whether hypertonic (7%) saline (HTS) attenuates brain injury by
improving cerebral perfusion pressure (CPP) and down-modulating acute inflamma-
tory responses in experimental bacterial meningitis in the newborn piglet. Twenty-five
newborn piglets were assorted into three groups: 6 in the control group (C), 10 in the
meningitis group (M), and 9 in the meningitis with HTS infusion group (H). Menin-
gitis was induced by intracisternal injection of 10
8 colony forming units of Escherichia
coli in 100  L of saline. 10 mL/kg of HTS was given intravenously as a bolus 6 hr
after induction of meningitis, thereafter the infusion rate was adjusted to maintain
the serum sodium level between 150 and 160 mEq/L. HTS significantly attenuated
meningitis-induced brain cell membrane disintegration and dysfunction, as indicated
by increased lipid peroxidation products and decreased Na
+, K
+-ATPase activity in
the cerebral cortex in M. HTS significantly attenuated acute inflammatory markers
such as increased intracranial pressure, elevated lactate level and pleocytosis in
the cerebrospinal fluid observed in M. Reduced CPP observed in M was also sig-
nificantly improved with HTS infusion. These findings implicate some attenuation
of the meningitis-induced alterations in cerebral cortical cell membrane structure
and function with HTS, possibly by improving CPP and attenuating acute inflam-
matory responses.
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MATERIALS AND METHODS
Animal preparation and surgical procedures
The experiments described herein were reviewed and app-
roved by the Institutional Animal Care and Use Committee
of the Samsung Biomedical Research Center (Seoul, Korea).
We also followed the institutional and National Institutes
of Health guidelines for laboratory animal care in this study.
Newborn piglets of mixed strain (Yorkshire, conventional
breed, purchased from Paju Farm, Paju, Gyeonggi-Do, Korea)
less than 3 days old, weighing 1.0-1.6 kg were used in this
study. Animals inhaled ether for sedation, and anesthesia was
induced with 5 mg/kg intravenous sodium thiopental. After
local injection with lidocaine (1%), tracheostomy was per-
formed and the piglet was paralyzed with 0.1 mg/kg intra-
venous pancuronium and ventilated with a neonatal pressure-
limited, time-cycled mechanical ventilator (Sechrist Infant
Ventilator, IV-100B; Sechrist Industries Co., Anaheim, CA,
U.S.A.). Ventilator settings were adjusted to keep PaO2 at
80-100 mmHg and PaCO2 at 35-45 mmHg. Supplemental
doses of sodium thiopental and pancuronium were given
every 2, 3 hr when spontaneous movement of the animal
including self-respiration was observed to maintain anesthe-
sia. Femoral arteries and veins were cannulated for blood pres-
sure monitoring, blood sampling, and medication and fluid
infusion, respectively. Electrocardiogram, oxygen saturation,
ICP, and blood pressure were continuously monitored using
a Hewlett-Packard neonatal monitoring system (Hewlett-
Packard model M1276A, Hewlett-Packard Co., MA, U.S.A.).
Cisternal puncture was done with a 22-gauge spinal needle
(Becton Dickinson, Franklin Lakes, NJ, U.S.A.), and the
needle was kept in situ for continuous ICP monitoring and
CSF sampling. Throughout the experiment, the piglet was
placed under the servo-controlled warmer (Airshields, Hat-
boro, PA, U.S.A.), and rectal temperature was maintained
between 38.0 and 39.0℃, which is normal for newborn
piglets.
Experimental protocol
The experimental protocol was schematized in Fig. 1. In
twenty five newborn piglets, preliminary study was done in
the control group (C, n=6) to determine the infusion rate of
HTS to maintain hypernatremia of 150-160 mEq/L, and the
rest was randomly assorted into the meningitis group (M,
n=10) and the meningitis with HTS infusion group (H, n=9).
After surgery and a stabilization period, meningitis was in-
duced by intracisternal injection of 108 colony forming units
of E. coli in 100  L of saline.
Continuous monitoring of heart rate, electrocardiogram,
oxygen saturation, ICP, and MAP were done for 10 hr after
bacterial inoculation, and CPP was calculated as MAP minus
ICP. Serum electrolytes concentration, arterial blood gas analy-
ses, and glucose and lactate concentration in the blood and
CSF were measured at baseline and every 2 hr for 10 hr after
bacterial inoculation. Leukocyte counts and bacterial titers in
the cerebrospinal fluid (CSF) were determined at baseline, 6
and 10 hr of the experiment.
In C and H, hypernatremia was induced by giving a bolus
of 10 mL/kg HTS (7%) for 30 min at 6 hr after intracisternal
bacterial inoculation. After a bolus infusion of HTS, contin-
uous infusion was begun at a rate of 4 mL/kg/hr by using infu-
sion pump. Then, if serum sodium concentration measured
every 30-45 min was between 150-160 mEq/L, infusion rate
was unaltered, if serum sodium concentration was above 160
mEq/L, infusion was stopped until the next serum sodium
concentration was determined, and if serum sodium concen-
tration was below 150 mEq/L, infusion rate was increased
to 8 mL/kg/hr. However, during the real experiment, only 5
piglets needed infusion rate alteration during HTS continu-
ous infusion. They all needed infusion stop at least once dur-
ing HTS continuous infusion because serum sodium concen-
tration exceeded 160 mEq/L. There was no incidence that
needed increase of infusion rate because serum concentration
dropped below 150 mEq/L. The other 10 piglets received
HTS at a constant rate (4 mL/kg/hr) all through the HTS con-
tinuous infusion (3.5 hr) because their serum sodium concen-
tration was maintained between 150-160 mEq/L at all times.
To match the volume of HTS infused and thus eliminate the
effect of differing volume on the outcomes, Ringer’s lactate
solution was infused as a bolus of 10 mL/kg and a subsequent
continuous infusion at a rate of 4 mL/kg/hr to 10 piglets in M.
Separately from HTS or Ringer’s lactate solution, D7.5W
solution was infused continuously at a rate of 4 mL/kg/hr to
the piglets in all experimental groups as the maintenance
fluid during the experiment.
As we tried to settle the debate as to whether higher serum
levels are not simply the result of sufficient amounts of HTS
in order to restore CPP, we decided to aim for a certain serum
level instead of a predetermined amount of volume in the
present study. The serum sodium concentration of 150-160
mEq/L selected in the present study was assumed to be clin-
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Fig. 1. The experimental scheme. ‘H’ means the meningitis with
hypertonic saline infusion group, ‘M’ means the meningitis control
group, ‘C’ means the hypertonic saline control group, ‘IC’ means
intracisternal, ‘HTS’ means hypertonic saline, and ‘RL’ means
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ically acceptable and optimal for maximal clinical effects (19)
and least side effects (6, 14). 
CSF leukocyte counts were measured using a hemocytome-
ter, arterial blood gases were measured on a blood gas analyzer
(Ciba-Corning Diagnotics Corp., Medfield, MA, U.S.A.),
and concentrations of glucose and lactate were measured using
a YSI model 2,300 dual analyzer (Yellow Springs Instrument
Co., Yellow Springs, OH, U.S.A.). Bacterial titers in the CSF
were determined by plating 10-fold dilutions on blood agar
plates overnight at 37℃in room air. At the end of each experi-
ment, brain cortex was harvested using a guillotine, rapidly
frozen in liquid nitrogen, and stored at -80℃ for further
biochemical analyses.
Biochemical analyses of brain cortex
Methods of brain cell membrane preparation and determi-
nation of cerebral cortical cell membrane Na
+, K
+-ATPase
activity, concentration of conjugated dienes, ATP and phos-
phocreatine (PCr) were described in detail previously (3).
Briefly, brain cell membranes were prepared according to
the method described by Harik et al. (20). The activity of
Na
+, K
+-ATPase was determined by subtracting the enzyme
activity in the presence of ouabain from the total activity in
the absence of ouabain (21). The concentration of conjugat-
ed dienes was determined using the method of Recknagel
and Glende (22). Brain ATP and PCr concentrations were
determined with a coupled enzyme assay using the method
of Lamprecht et al. (23).
Statistics
Data were analyzed by Kruskal-Wallis test (nonparametric
ANOVA) for intergroup comparisons at each time point. To
detect significant changes over time within each group and
between groups, data were compared using repeated measures
ANOVA with Bonferroni correction. Statistical analyses des-
cribed above were done using SPSS software program version
11.5. A p value of less than 0.05 was considered significant.
Data are given as mean±standard error (S.E.).
RESULTS
Physiologic and laboratory data
Physiologic and laboratory data from the three experimen-
tal groups at 6 hr (before HTS infusion) and 10 hr (the end
of the experiment, 4 hr after HTS infusion) are summarized
in Table 1. There were no significant differences in the base-
line (at 0 hr) values of these variables between the three experi-
mental groups. 
Serum sodium concentrations had risen to 150-160 mEq/L
after the bolus infusion of HTS and remained at that level
to the end of the experiment in C and H, while remaining
at the baseline level in M (Fig. 2). 
Significantly elevated lactate level and leukocyte counts
in the CSF observed in M compared to C, were significantly
improved in H. Elevated bacterial colony counts and decreased
glucose level in the CSF observed in M and H were not sig-
nificantly different during the experiment.
Changes in ICP, MAP, CPP
The changes in ICP, MAP, and CPP in the three experi-
mental groups during the experiment are shown in Fig. 3.
In C, there were no significant changes in ICP, MAP, and
CPP throughout the experiment. In M, MAP decreased grad-
At 6 hr (before HTS infusion)
C (n=6) M (n=10) H (n=9)
At 10 hr (4 hr after HTS infusion)
C (n=6) M (n=10) H (n=9)
Heart rate (/min) 195±17 224±14 215±10 184±11 213±11 203±8
Serum sodium (mEq/L) 136.1±0.8 136.3±1.3 134.2±1.1 155.4±0.6 137.0±1.3* 154.3±0.4
�
Arterial pH 7.31±0.01 7.35±0.02 7.33±0.01 7.31±0.03 7.26±0.03 7.30±0.01
PaO2 (mmHg) 79±28 3 ±88 2 ±38 0 ±18 3 ±78 0 ±3
PaCO2 (mmHg) 45±14 2 ±14 3 ±14 6 ±14 3 ±34 3 ±1
Base excess (mEq/L) -2.0±1.3 -2.0±0.9 -1.0±0.8 -3.0±1.5 -8.4±1.6 -3.1±1.2
Blood glucose (mg/dL) 103±29 0 ±58 9 ±59 2 ±57 4 ±58 2 ±5
CSF glucose (mg/dL) 85±34 4 ±4* 44±3* 89±42 7 ±4* 32±5*
Blood lactate (mM/L) 1.3±1.1 3.0±0.6 1.9±0.2 1.5±0.2 3.9±0.9 2.2±0.3
CSF lactate (mM/L) 1.7±0.1 6.0±0.4* 6.5±0.3* 2.1±0.1 11.2±0.9* 8.5±0.3*
,�
At 0 hr (baseline) At 10 hr
Leukocyte count in CSF (/ L) 84±58 6 ±47 8 ±49 2 ±7 1036±55* 762±32*
,�
Bacterial colony count in CSF (10
5/ L) 0 3.2±0.5* 2.7±0.3* 0 2.7±0.3* 2.8±0.6*
Table 1. Physiologic and laboratory data at 6 hr and 10 hr of experiment in each group of newborn piglets
Data are given as mean±standard error (S.E.). ‘HTS’ means hypertonic saline, ‘H’ means the meningitis with hypertonic saline infusion group, ‘M’ means
the meningitis control group, ‘C’ means the hypertonic saline control group, and ‘CSF’ means cerebrospinal fluid.
*p<0.05 compared to C, 
�
p<0.05 compared to M.Hypertonic Saline in Bacterial Meningitis 873
ually during the experiment, and became significantly lower
compared to C 8 hr after the induction of meningitis, and this
abnormality was improved in H after HTS infusion. ICP
increased progressively, and became significantly elevated 2
hr after the induction of meningitis in M and H, and this ele-
vation was significantly attenuated after HTS infusion in H.
CPP, calculated as MAP minus ICP, decreased gradually and
became significantly lower compared to C 6 hr after the induc-
tion of meningitis in M and H, and this reduction was sig-
nificantly attenuated in H after HTS infusion.
Biochemical Data in Cerebral Cortex
Decreased cerebral cortical cell membrane Na
+, K
+-ATPase
activity and increased level of lipid peroxidation products (con-
jugated dienes) observed in M compared to C, indicative of
meningitis-induced alterations in brain cell membrane func-
tion and structure, were slightly but significantly improved in
H (Table 2). Marginally reduced concentrations of cerebral ATP
and PCr observed in M compared to C failed to improve in H.
DISCUSSION
In the present study, HTS infusion significantly decreased
lactate level and leukocyte count in the CSF, and increased
CPP in the newborn piglet model of bacterial meningitis.
HTS has been shown to possess significant anti-inflammatory
capabilities in various in vitro studies (16-18, 24). In our pre-
vious studies of experimental neonatal bacterial meningitis
(3, 25), increased ICP and elevated CSF lactate level were
primarily attributable to acute inflammatory responses in
the subarachnoid space rather than to brain edema and cere-
bral energy depletion from cerebral ischemia, respectively.
Thus our data of significant attenuation of meningitis-induced
increase in lactate level and leukocyte count in the CSF with
HTS infusion suggest the possible in vivo anti-inflammatory
effects of HTS. However, we adopted only leukocyte count
in the CSF as an inflammatory marker in this study. Other
inflammatory markers such as tumor necrosis factor- , inter-
leukins were not measured. Moreover, although statistically
significant, the difference of leukocyte count in the CSF between
H and M was small. This is a major drawback of our study.
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Fig. 3. Time course of mean arterial pressure (A), intracranial pres-
sure (B), and cerebral perfusion pressure (C) in newborn piglets
in each experimental group. ‘H’ means the meningitis with hyper-
tonic saline infusion group, ‘M’ means the meningitis control group,
‘C’ means the hypertonic saline control group, and ‘HTS’ means
hypertonic saline. Data are expressed as mean±standard error.
*p<0.05 compared to C, 
� p<0.05 compared to M.
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Fig. 2. Time course of serum sodium level. ‘H’ means the menin-
gitis with hypertonic saline infusion group, ‘M’ means the meningitis
control group, ‘C’ means the hypertonic saline control group, and
‘HTS’ means hypertonic saline. Data are expressed as mean±
standard error. 
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C (n=6) M (n=10) H (n=9)
Na
+, K
+-ATPase activity 49.8±0.9 45.0±0.4* 47.1±0.8*
,�
( M Pi/mg protein/hr)
Conjugated dienes 0.87±0.04 1.11±0.03* 0.98±0.05
�
( M/g protein)
ATP (mM/kg) 3.4±0.1 2.7±0.2* 3.0±0.2
Phosphocreatine (mM/kg) 3.4±0.1 2.8±0.1* 3.1±0.1
Table 2. Biochemical data in the cerebral cortex of the newborn
piglets in each experimental group
A
B
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Therefore, it seems to be precipitate to conclude that HTS
showed an anti-inflammatory effect in this study. Further
studies will be necessary to prove the anti-inflammatory effects
of HTS in bacterial meningitis.
Besides the acute inflammatory responses, cerebral ischemia
resulting from the critical reduction of CPP with intracranial
hypertension and systemic hypotension may have an addi-
tional and even critical role in the pathogenesis of brain injury
during bacterial meningitis (2, 4, 5, 26, 27). In accordance
with other studies (26, 27), our data of maintenance of ade-
quate CPP by simultaneous improvement of reduced MAP
and increased ICP with HTS infusion in this study suggest
the possibility that HTS could also be an attractive adjunc-
tive therapy to prevent cerebral ischemia and the ensuing
brain injury in bacterial meningitis.
The anti-inflammatory property of HTS might not be
attributable to a stabilization of hemodynamics because we
have observed that maintenance of adequate CPP and cere-
bral blood flow with dopamine infusion did not attenuate
the acute inflammatory responses in our previous study of
experimental bacterial meningitis (26). Which effect of HTS,
either anti-inflammatory effect or improvement of CPP, might
have been primary in the attenuation of brain injury observed
in the present study is a subject of intricacy, because these
two effects are related to each other, in which as meningeal
inflammation decreases, CPP accordingly increases (28). Fur-
ther studies controlled for MAP, ICP, and both MAP and
ICP, respectively could make clear which effect of HTS is
the major one in reducing brain injury.
Oxygen free radicals attack double bonds of polyunsatu-
rated fatty acids in cell membrane in a process called lipid
peroxidation (29). Degradation of cell membrane structure
by lipid peroxidation reduces Na
+, K
+-ATPase activity (30)
and result in brain cell dysfunction that may lead to osmotic
cell swelling and neuronal death (31). In the present study,
increased lipid peroxidation products and reduced Na
+, K
+-
ATPase activity observed in M were slightly but significantly
improved in H. These findings implicate some attenuation
of the meningitis-induced alterations in cerebral cortical cell
membrane structure and function with HTS. However, as the
extent of the attenuation is very small although statistically
significant, the clinical significance of the neuroprotective
effect of HTS remains doubtful. Further studies recruiting
more definite tools such as pathology and functional assess-
ment for the evaluation of brain injury could elucidate the
neuroprotective effect of HTS. Cerebral high energy phos-
phate compounds (ATP/PCr) in M were reduced only margi-
nally compared to C, and failed to demonstrate improvement
in H. These findings suggest that the mitochondrial oxida-
tive metabolism in M at this early stage of meningitis remains
relatively intact despite anaerobic glycolysis due to inflam-
matory responses and cerebral ischemia from reduced CPP,
and the effect of HTS is minimal.
The newborn piglet bacterial meningitis model has been
well established throughout our previous studies (3, 25, 32-
34). The piglet brain is comparable in maturity to human
brain at birth (35). Furthermore, because it is similar in size
to a preterm infant, methods for monitoring various physio-
logic variables and maintaining it in good condition through-
out the experiment were also feasible.
In this study, E. coli was used to induce meningitis because
it is the most frequent Gram-negative pathogen of neonatal
meningitis. In the majority of our previous studies of exper-
imental bacterial meningitis, 108 colony forming units of E.
coli was used to induce meningitis. In one study, 109 colony
forming units of E. coli was used. However, there was no
remarkable difference in the severity of meningitis indicat-
ed by the ICP, CSF profiles, and brain tissue chemistry find-
ings between the two doses of E. coli.
In the present study, we maintained the rectal temperature
of newborn piglets within the normal range by monitoring
and modifying the piglet’s temperature with the thermoreg-
ulatory devices as in our previous studies (3, 4, 25, 26). We
have already shown that rectal and brain temperatures were
equivalent in our previous hypothermia study with the new-
born piglet (32). Prevention of fever by maintaining normo-
thermia in our controlled animals might have contributed to
the reduced inflammatory responses in the present study. Our
previous observation that acute inflammatory responses could
be attenuated by therapeutically induced systemic hypother-
mia in experimental bacterial meningitis (32), also support
that temperature could be an important confounding vari-
able of the inflammatory responses during meningitis. How-
ever, most neonates with sepsis have a normal temperature
at admission to the neonatal intensive care unit (36), and fever
does not seem to a prominent feature in neonates during sys-
temic bacterial infections such as sepsis and meningitis unlike
that in adults. Thus, it is thought that the strict maintenance
of normothermia and prevention of fever or hypothermia in
our animal models of experimental neonatal bacterial menin-
gitis would be more relevant and appropriate to simulate the
clinical situation.
Intracisternal injection of bacteria to induce meningitis in
the present study might cause a different situation and dif-
ferent permeability of the blood-brain barrier (BBB) than if
infection occurs through the blood stream. Although we have
observed that the BBB permeability and acute inflammatory
responses were directly related to the concentration of the
bacteria in the CSF space (33, 34), not to the routes of bacte-
rial entry into the CSF (37), and the BBB permeability to the
glucose increased markedly only 1 hr after intracisternal inoc-
ulation of bacteria (3) in our previous studies, further studies
will be necessary to determine whether the BBB would be
more permeable if the infection have occurred through bac-
teremia rather than direct intracisternal bacterial injection.
As bacterial meningitis is usually diagnosed only after
becoming fully symptomatic, it would be clinically more
relevant to test the efficacy of any adjunctive treatment whenHypertonic Saline in Bacterial Meningitis 875
the symptoms of bacterial meningitis are full-blown. To sim-
ulate the clinical situation, HTS was infused 6 hr after induc-
tion of meningitis when the acute inflammatory responses
reached a maximal level (3, 4, 25, 26), and the animals were
sacrificed 4 hr after beginning of HTS infusion because it was
the least indispensable but best affordable time period (3, 25,
33, 34, 37) to test the efficacy of HTS as an adjunctive ther-
apy in bacterial meningitis. The trend of any changes observed
at 4 hr did not change significantly afterward up to 8 hr in
our previous studies of experimental meningitis (4, 26).
In summary, HTS significantly improved CPP, decreased
the acute inflammatory responses as evidenced by decreased
lactate level and leukocyte count in the CSF, and attenuated
the alterations of cerebral cortical cell membrane function
and structure indicated by decreased Na
+, K
+-ATPase activity
and increased conjugated dienes level without significant
adverse effects during the full-blown phase of experimental
E. coli meningitis. These findings suggest the potential neuro-
protective effect of HTS in bacterial meningitis. However,
further well-designed controlled studies adopting more inflam-
matory markers and more definite tools for the evaluation of
brain injury are warranted to clarify the neuroprotective effect
of HTS and its mechanisms in bacterial meningitis. 
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